Direct|acting antiviral agents

Direct Acting Antiviral (DAA) Drug Access Protocol

o WHAT IS DIRECT ACTING ANTIVIRAL (DAA's)?. Direct-acting antivirals (DAA's) are a relatively new class of medication used to treat Hepatitis C ...

Drug–Drug Interactions of Newly Approved Direct-Acting Antiviral

This review summarizes researches of DDIs focusing on newly approved DAAs (elbasvir, grazoprevir, velpatasvir, voxilaprevir, glecaprevir, pibrentasvir)

Impact of successful treatment with direct-acting antiviral agents on ...

The cure of chronic hepatitis C infection with DAA has a short term positive impact on HRQoL with improvement in mobility, pain/discomfort, anxiety/depression, ...

Hepatitis C Treatment by Directly Acting Antiviral Agents and Its ...

Our study showed that treatment with directly acting antiviral treatment improved glycaemic control in HCV infected patients.

Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related ...

Preliminary results are shown. Table 3. Summary of the Study Results for Each Direct-Acting Antiviral ...

Hepatitis C Retreatment With First-Line Direct Acting Antiviral Drugs

We report our experience of HCV retreatment using these first-line drugs, in a setting where second-line anti-HCV drugs are not available.

Direct-acting antiviral interferon-free regimens to treat chronic ...

Direct-acting antivirals used as part of interferon-free regimens for the treatment of chronic hepatitis C infection are: daclatasvir (Daklinza▽); ...

Hepatitis C in ON: Testing, Direct-Acting Antiviral ... - YouTube

... direct-acting antiviral drugs (DAAs), which will help to meet the World Health Organization's (WHO) HCV elimination targets by 2030. Public ...

Impact of Direct Acting Antiviral Agent Therapy upon Extrahepatic ...

Summary. DAAs improve extrahepatic manifestations of CHC virus infection. Future studies are needed to evaluate the long-term durability of ...

Direct-Acting Antiviral Agents Reduce Risk of Hepatocellular Cancer ...

FINDINGS: In Veterans treated with direct-acting antiviral agents, SVR was associated with a 76% reduction in the risk of developing hepatocellular cancer ...

Hepatitis C - World Health Organization (WHO)

Direct-acting antiviral medicines (DAAs) can cure more than 95% of persons with hepatitis C infection, but access to diagnosis and treatment ...

Impact of direct-acting antiviral agents on the risk for hepatocellular ...

Impact of direct-acting antiviral agents on the risk for hepatocellular carcinoma ... Correspondence to: Dr. Xavier Adhoute. Department of Hepato-Gastroenterology ...

Changing Urban–Rural Disparities in the Utilization of Direct-Acting ...

Among 204,018 new patients with hepatitis C virus infection, about 30% received direct-acting antiviral agents during 2014–2017. Cumulative ...

Safety and efficacy of direct-acting antiviral drugs in the treatment of ...

Hepatitis C virus (HCV) infection is a major cause of liver-related morbidity and mortality among thalassemic patients. Direct-acting ...

Impact of direct-acting antiviral agents-induced SVR on the long ...

Data are sparse, however, about the long-term benefits of direct-acting antiviral agents (DAAs) in terms of risk reduction for hepatocellular carcinoma (HCC).

Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related ...

In one trial, 12 weeks of triple therapy with sofosbuvir, ledipasvir, and RBV and of combination therapy with sofosbuvir and ledipasvir resulted ...

Clinically Relevant Drug Interactions with Direct Acting Antivirals ...

David Hachey, PharmD, reviews clinically relevant interactions between HIV antiretroviral medications and hepatitis C direct-acting ...

In Brief: Hepatitis B Reactivation with Direct-Acting Antiviral Drugs ...

Twenty-four cases of HBV reactivation occurring during treatment with direct-acting antiviral drugs for HCV were identified from the FDA Adverse Event ...

Virus Elimination by Direct-Acting Antiviral Agents Impacts Glucose ...

This study aimed to analyze the independent factors associated with IR and to evaluate the changes in glucose homeostasis in chronic HCV-infected patients ...

Sustained virologic response to direct-acting antiviral agents ...

New interferon-free therapies based on combinations of direct-acting antiviral agents (DAAs) have progressively improved HCV eradication, ...